OBJECTIVES: Endoscopic ablation of Barrett's esophagus can bury metaplastic glands
under a layer of neosquamous epithelium. To explore the frequency and importance of …

Endoscopic submucosal dissection was developed in Japan, early in this century, to provide
a minimally invasive yet curative treatment for the large numbers of patients with early …

Background and study aims: The role of endoscopic submucosal dissection (ESD) in
Barrett's neoplasia is ill-defined, although it might provide a higher curative resection rate …

Background and study aim: It is commonly assumed that ablation of any remaining Barrett's
epithelium after endoscopic resection of early Barrett's neoplasia improves outcome by …

Background: Most risk estimations for lymph node metastasis in adenocarcinoma of the
esophagus and cardia (AEC) with invasion into the muscularis mucosae (m3) or submucosa …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) reduces the risk of esophageal
adenocarcinoma (EAC) in patients with Barrett's esophagus (BE) with high-grade dysplasia …

Background and Aims Previous estimates of incidence of intestinal metaplasia (IM)
recurrence after achieving complete remission of IM (CRIM) through endoscopic therapy of …

Background & Aims After radiofrequency ablation (RFA), patients may experience
recurrence of Barrett's esophagus (BE) after complete eradication of intestinal metaplasia …

Background and study aims: Endoscopic submucosal dissection (ESD) of early
gastrointestinal tumors has been shown to achieve complete resection rates superior to …

METHODS: In a prospective clinical trial, 11 academic and community centers recruited
consecutive patients with BE of 1–6 cm length and low-grade dysplasia, high-grade …